跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SIBNAYAL 24 MEQ GRANULOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SIBNAYAL 24 MEQ GRANULOS DE LIBERACION PROLONGADA
Approved
STANDARD
SIBNAYAL 24 MEQ GRANULOS DE LIBERACION PROLONGADA
Advicenne
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 9, 2023
Approval ID
6a99f9c314cb4d67
Company
Advicenne
Type
Standard
Approval Details
Approval Id
6a99f9c314cb4d67
Drug Cima Aemps Name
SIBNAYAL 24 MEQ GRANULOS DE LIBERACION PROLONGADA
Register Number
1201517007
Holder Company Name
Advicenne
Marketing Company Name
Spa Farma Iberica S.L.
Holder Company Detail Path
/organization/advicenne
Authorization Date
2023-05-09
Dosage Form
GRANULADO DE LIBERACIÓN PROLONGADA
Dose
24 mEq
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Advicenne
Company Detail Path
/organization/advicenne
Company Information
Pharmaceutical Company Name
ADVICENNE
Country Name
France
City Name
paris 2 e arrondissement,ile-de-france,country_fr
Address
ADVICENNE PHARMA ADVICENNE
Active Ingredients
CITRATO POTASIO
846,58 mg
POTASIO BICARBONATO
1581,56 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 9, 2023
Approval ID
6a99f9c314cb4d67
Type
Standard
Back to CIMA-AEMPS Approvals
